← Signal Board

Revolution Medicines company information

레볼루션 메디신NASDAQ:RVMD · Nasdaq · Healthcare · sector #13
$207.68+0.50%
2026-10-05 close

Revolution Medicines's company information is shown as of 2026-10-05. It is a security listed on Nasdaq, ticker RVMD. There are 14 published related companies.

About this company

Revolution Medicines last closed at $207.68 (+0.50%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq.

1 guru reporting 13F holdings — Stanley Druckenmiller

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Suppliers, competitors and related stocks

  • AmgenCompetitor

    RAS/MAPK 계열 항암제 개발에서 경쟁

  • Mirati TherapeuticsCompetitor

    KRAS 표적 항암제 개발 경쟁(현재 BMS에 인수됨)

  • Bristol-Myers SquibbCompetitor

    고형암·표적항암제 파이프라인에서 직접 경쟁

  • GenentechCompetitor

    종양학 대형사로 표적항암제 개발 경쟁

  • NovartisCompetitor

    RAS/종양학 신약 개발에서 경쟁

  • Eli LillyCompetitor

    표적항암제 및 분자표적 치료제 개발 경쟁

  • PfizerCompetitor

    종양학 포트폴리오에서 경쟁

  • RocheCompetitor

    항암제 대형사로 종양학 신약 경쟁

  • AmgenRelated theme

    정밀의학·표적항암제 개발 테마

  • Bristol-Myers SquibbRelated theme

    항암 신약 상업화 및 임상개발 테마

  • GenentechRelated theme

    종양학/면역항암제 연구개발 테마

  • Mayo ClinicCustomer

    임상시험·연구 협력 파트너로 활용 가능

  • Memorial Sloan Kettering Cancer CenterCustomer

    임상시험 및 연구 협력 주요 병원

  • NCICustomer

    항암제 임상 및 연구 협력 기관

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $2.8B(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Revolution Medicines notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q